home / stock / okyo / okyo quote
Last: | $1.51 |
---|---|
Change Percent: | 4.73% |
Open: | $1.41 |
Close: | $1.51 |
High: | $1.5175 |
Low: | $1.41 |
Volume: | 3,225 |
Last Trade Date Time: | 05/09/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.51 | $1.41 | $1.51 | $1.5175 | $1.41 | 3,225 | 05-09-2024 |
$1.48 | $1.4033 | $1.48 | $1.49 | $1.4001 | 4,870 | 05-08-2024 |
$1.4242 | $1.455 | $1.4242 | $1.47 | $1.42 | 3,270 | 05-07-2024 |
$1.49 | $1.51 | $1.49 | $1.51 | $1.44 | 11,477 | 05-06-2024 |
$1.52 | $1.5571 | $1.52 | $1.5571 | $1.52 | 10,108 | 05-03-2024 |
$1.545 | $1.5 | $1.545 | $1.545 | $1.48 | 29,799 | 05-02-2024 |
$1.5 | $1.485 | $1.5 | $1.5 | $1.485 | 1,832 | 05-01-2024 |
$1.5 | $1.47 | $1.5 | $1.5 | $1.46 | 2,903 | 04-30-2024 |
$1.4606 | $1.57 | $1.4606 | $1.57 | $1.4606 | 13,926 | 04-29-2024 |
$1.4701 | $1.46 | $1.4701 | $1.55 | $1.435 | 11,767 | 04-26-2024 |
$1.4467 | $1.3805 | $1.4467 | $1.4467 | $1.38 | 3,437 | 04-25-2024 |
$1.41 | $1.38 | $1.41 | $1.46 | $1.38 | 50,001 | 04-24-2024 |
$1.4 | $1.43 | $1.4 | $1.45 | $1.3001 | 28,547 | 04-23-2024 |
$1.36 | $1.4 | $1.36 | $1.43 | $1.32 | 62,597 | 04-22-2024 |
$1.4027 | $1.41 | $1.4027 | $1.4523 | $1.3901 | 13,934 | 04-19-2024 |
$1.4653 | $1.38 | $1.4653 | $1.4653 | $1.38 | 8,176 | 04-18-2024 |
$1.41 | $1.43 | $1.41 | $1.5 | $1.3754 | 8,847 | 04-17-2024 |
$1.45 | $1.38 | $1.45 | $1.45 | $1.3166 | 21,790 | 04-16-2024 |
$1.4 | $1.4 | $1.4 | $1.4 | $1.3301 | 14,009 | 04-15-2024 |
$1.385 | $1.33 | $1.385 | $1.4 | $1.3 | 8,658 | 04-12-2024 |
News, Short Squeeze, Breakout and More Instantly...
OKYO Pharma Limited Company Name:
OKYO Stock Symbol:
NASDAQ Market:
LONDON and NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment diseases ...
LONDON and NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment disease...
LONDON and NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ:OKYO), a clinical-stage biopharmaceutical company developing...